drugset / Trial / NCT06622291

Perioperative Nitric Oxide Prevents Acute Kidney Injury in Acute Type A Aortic Dissection Patients

NCT06622291

Phase 4 Completed 106 enrolled Beijing Anzhen Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

The goal of this clinical trial is to determine the effectiveness of exogenous nitric oxide therapy in reducing the occurrence of acute kidney injury in patients with acute type A aortic dissection. Additionally, it aims to assess the safety of exogenous nitric oxide therapy.

Timeline

Start
2024-11-30
Primary completion
2025-11-01
Completion
2026-02-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 60 ppm Other